Marcela V Maus
Harvard University
H-index: 73
North America-United States
Top articles of Marcela V Maus
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
Clinical Cancer Research
2024/4/2
Context matters: Tumor microenvironments impact cellular therapy success
Cell Reports Medicine
2024/4/16
Marcela V Maus
H-Index: 48
Intraventricular CARv3-TEAM-E T cells in recurrent glioblastoma
New England Journal of Medicine
2024/4/11
Current and emerging pharmacotherapies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis-like syndrome due to CAR T cell therapy
2024/4/7
Marcela V Maus
H-Index: 48
Tandem CAR-T cells against mesothelin and MUC16ectoto overcome tumor-antigen heterogenicity
Cancer Research
2024/3/22
Marcela V Maus
H-Index: 48
Developing a lenalidomide-inducible safety switch for CAR T cell therapy
Cancer Research
2024/3/22
Improving CAR T cell efficacy in pancreatic cancer using an in vivo CRISPR Cas9 screen
Cancer Research
2024/3/22
National Survey of FACT-Accredited Cell Processing Facilities: Assessing Preparedness for Local Manufacturing of Immune Effector Cells
Transplantation and Cellular Therapy
2024/3/16
Marcela V Maus
H-Index: 48
Second Primary Malignancies After Commercial CAR T Cell Therapy: Analysis of FDA Adverse Events Reporting System (FAERS)
Blood
2024/3/15
Moataz Ellithi
H-Index: 3
Marcela V Maus
H-Index: 48
Chimeric antigen receptor t cells targeting the tumor microenvironment
2020/4/16
Understanding Mechanisms of Response to CAR T-cell Therapy through Single-Cell Sequencing: Insights and Challenges
2024/3/1
Marcela V Maus
H-Index: 48
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7
Leukemia
2024/3
Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral blood
Cytometry Part B: Clinical Cytometry
2024/2/28
Marcela V Maus
H-Index: 48
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help
Blood Advances
2024/2/27
Genetic retargeting of E3 ligases to enhance CAR T cell therapy
Cell Chemical Biology
2024/2/15
William Lin
H-Index: 1
Johannes Kreuzer
H-Index: 9
Robert Morris
H-Index: 1
Marcela V Maus
H-Index: 48
Max Jan
H-Index: 11
Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunology
2024/2/13
Marcela V Maus
H-Index: 48
Max Jan
H-Index: 11
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
Nature Medicine
2024/1/9
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
2024/1/9
Library-based single-cell analysis of CAR signaling reveals drivers of in vivo persistence
bioRxiv
2024/1/1
Avlant Nilsson
H-Index: 9
Marcela V Maus
H-Index: 48
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma
Blood
2023/11/28
Co-Authors
